Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 8:5:100091.
doi: 10.1016/j.dadr.2022.100091. eCollection 2022 Dec.

Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use

Erin L Winstanley  1   2 , Emily P Thacker  3 , Lyn Yuen Choo  4 , Laura R Lander  1   2 , James H Berry  1   2 , Babak Tofighi  5
Affiliations

Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use

Erin L Winstanley et al. Drug Alcohol Depend Rep. .

Abstract

Background: While barriers to accessing buprenorphine (BUP) therapy have been well described, little is known about pharmacy-related barriers. The objective of this study was to estimate the prevalence of patient-reported problems filling BUP prescriptions and determine whether these problems were associated with illicit use of BUP. The secondary objectives included identifying motivations for illicit BUP use and the prevalence of naloxone acquisition among patients prescribed BUP.

Methods: Between July 2019 and March 2020, 139 participants receiving treatment for an opioid use disorder (OUD) at two sites within a rurally-located health system, completed an anonymous 33-item survey. A multivariable model was used to assess the association between pharmacy-related problems filling BUP prescriptions and illicit substance use.

Results: More than a third of participants reported having problems filling their BUP prescription (34.1%, n = 47) with the most commonly reported problems being insufficient pharmacy stock of BUP (37.8%, n = 17), pharmacist refusal to dispense BUP (37.8%, n = 17), and insurance problems (34.0%, n = 16). Of those who reported illicit BUP use (41.5%, n = 56), the most common motivations were to avoid/ease withdrawal symptoms (n = 39), prevent/reduce cravings (n = 39), maintain abstinence (n = 30), and treat pain (n = 19). In the multivariable model, participants who reported a pharmacy-related problems were significantly more likely to use illicitly obtained BUP (OR=8.93, 95% CI: 3.12, 25.52, p < 0.0001).

Conclusion: Efforts to improve BUP access have primarily focused on increasing the number of clinicians waivered to prescribe; however, challenges persist with BUP dispensing and coordinated efforts may be needed to systematically reduce pharmacy-related barriers.

Keywords: Buprenorphine; Diversion; Naloxone; Opioid use disorder.

PubMed Disclaimer

Conflict of interest statement

No conflicts declared.

Figures

Fig 1
Fig. 1
Motivations for illicit buprenorphine use in the past year (n = 56).
See this image and copyright information in PMC

References

    1. Andrilla C.H.A., Patterson D.G. Tracking the geographic distribution and growth of clinicians with a DEA waiver to prescribe buprenorphine to treat opioid use disorder. J. Rural Health. 2022;38(1):87–92. - PubMed
    1. Andrilla C.H.A., Coulthard C., Larson E.H. Barriers rural physicians face prescribing buprenorphine for opioid use disorders. Ann. Fam. Med. 2017;15:359–362. - PMC - PubMed
    1. Bakhireva L.N., Bautista A., Cano S., Shrestha S., Bachyrycz A.M., Cruz T.H. Barriers and facilitators to dispensing of intranasal naloxone by pharmacists. Subst. Abus. 2017;39(3):331–341. - PubMed
    1. Bazazi A.R., Yokell M., Fu J.J., Rich J.D., Zaller N.D. Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users. J. Addict. Med. 2011;5(3):175–180. - PMC - PubMed
    1. Beetham T. Buprenorphine prior authorization removal: low hanging fruit in the opioid epidemic fight. Harv. Public Health Rev. 2019;25:1–5.

LinkOut - more resources